PER percheron therapeutics limited

Ann: Trading Halt, page-127

  1. 4,275 Posts.
    lightbulb Created with Sketch. 2047
    I hope so Uboy

    https://techstory.in/biogen-inc-to-...euticals-in-6-5-billion-deal/#google_vignette

    Also Uboy of Note not so long ago Duvysat was approved for ambulatory but they are in the same field as us none cure targeting inflamation in ciombination with and replacement of steroids , [plus they have started a ph3 clinical trial in Feb this year in the none ambvulant due to finish in 2026 i think from memory

    They have also just released their price point of $700k per treatment

    So not sure how they price the drug but the minimum cost pp in the dmd field is $700k
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.